Buscar resultados de ensayos clínicos
Nephrosis, Lipoid - 25 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease Condición: Minimal Change Disease Fecha: 2009-09-21 Intervenciones:
|
Recruiting |
Nombre del estudio: Myfortic® for Minimal Change Nephrotic Syndrome (MCNS): a Randomized Study Condición: Nephrosis, Lipoid Fecha: 2010-08-13 Intervenciones:
|
Completed |
Nombre del estudio: Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Syndrome Condición: Minimal Change Disease Fecha: 2010-03-10 Intervenciones: Drug: Tacrolimus tacrolimus 0.05mg/kg bid for 12 weeks corticosteroid 0.3 - 0.5mg/kg qd |
Completed |
Nombre del estudio: Latent Viral Infection of Lymphoid Cells in Idiopathic Nephrotic Syndrome Condición: NEPHROSIS, LIPOID Fecha: 2007-12-19 |
Completed |
Nombre del estudio: The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy Condición: IgA Nephropathy Fecha: 2011-10-07 Intervenciones: Drug: Prednisone or Prednisolone daily single dose of 1mg/kg (maximum 80mg) or alternate day single dose |
Completed |
Nombre del estudio: Rituximab in Multirelapsing Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS) Condición: Nephrotic Syndrome Fecha: 2009-09-21 Intervenciones: Drug: Rituximab Rituximab (375 mg/m2) will be given as a single intravenous infusion after reconstitutio |
Not yet recruiting |
Nombre del estudio: Valproic Acid for Idiopathic Nephrotic Syndrome Condición:
Intervenciones: Procedure: Kidney Biopsy Patients scheduled to undergo a clinically indicated kidney biopsy will be requ |
Completed |
Nombre del estudio: Retinoids for Minimal Change Disease and Focal Segmental Glomerulosclerosis Condición:
Fecha: 2004-12-01 Intervenciones:
|
Recruiting |
Nombre del estudio: Pilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD) Condición: Nephrotic Syndrome Fecha: 2015-10-29 Intervenciones:
|